Logo-ijhpm
Int J Health Policy Manag. 2022;11(6): 768-776. doi: 10.34172/ijhpm.2020.215
PMID: 33233033        PMCID: PMC9309918

Original Article

The Impact of Tiered-Pricing Framework on Generic Entry in Canada

Wei Zhang 1,2 ORCID, Huiying Sun 1, Daphne P. Guh 1, Larry D. Lynd 1,3, Aidan Hollis 4, Paul Grootendorst 5, Aslam H. Anis 1,2 * ORCID

Cited by CrossRef:

1- Son K. Market Exclusivity of the Originator Drugs in South Korea: A Retrospective Cohort Study. Front Public Health. 2021;9 [Crossref]
2- McGee M, Chiu K, Moineddin R, Sud A. The Impact of Suboxone’s Market Exclusivity on Cost of Opioid Use Disorder Treatment. Appl Health Econ Health Policy. 2023;21(3):501 [Crossref]